Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
International Journal of Pharmaceutics|December 19, 2021
pH-responsive oleic acid based nanocarriers: Melanoma treatment strategiesFederica Rinaldi, Jacopo Forte, Giada Pontecorvi, et al.Cancer Research|April 18, 2008
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanismsFederica Felicetti, M Cristina Errico, Lisabianca Bottero, et al.Molecular Endocrinology (Baltimore, Md.)|July 17, 2012
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcomaCecilia Garofalo, Caterina Mancarella, Andrea Grilli, et al.Pigment Cell & Melanoma Research|June 30, 2011
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanomaGianfranco Mattia, M Cristina Errico, Federica Felicetti, et al.Italian Journal of Pediatrics|March 8, 2020
Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot studyIsabella Tarissi De Jacobis, Rosa Vona, Elisabetta Straface, et al.Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.Journal of Experimental & Clinical Cancer Research : CR|June 23, 2019
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-ASimona Caporali, Adriana Amaro, Lauretta Levati, et al.International Journal of Cancer|February 13, 2013
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathwayM Cristina Errico, Federica Felicetti, Lisabianca Bottero, et al.Journal of Personalized Medicine|September 28, 2024
Recommendations for the Application of Sex and Gender Medicine in Preclinical, Epidemiological and Clinical ResearchAnnamaria Cattaneo, Maria Bellenghi, Eliana Ferroni, et al.Plos One|February 26, 2013
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanomaNadia Felli, Federica Felicetti, Anna Maria Lustri, et al.Pageof 5